Palpitations on Mounjaro: separating the facts from the fear

The biggest misconception: palpitations mean Mounjaro is harming your heart

The most common thing people worry about when they feel their heart race or flutter on Mounjaro is that the medicine is directly damaging their cardiovascular system. That fear is understandable. It is also, in most cases, wrong.

Palpitations during the early weeks of tirzepatide treatment are more often a downstream effect of the GI side effects than a heart problem in their own right. When nausea, vomiting or diarrhoea reduce your fluid intake, even mild dehydration can raise your resting heart rate enough that you notice it. A heart beating at 90 beats per minute when you are used to 65 can feel dramatic without being dangerous.

There is also a direct pharmacological angle worth understanding. Tirzepatide activates GLP-1 receptors, which are present in cardiac tissue. The NHS tirzepatide patient information acknowledges a modest, transient increase in heart rate as something some people experience. For most this is slight and passes without any treatment. It is not the same as arrhythmia, and there is no evidence from the SURMOUNT clinical programme that tirzepatide increases the risk of serious cardiac events in people without pre-existing heart disease.

Understanding that distinction (a felt sensation versus a structural or rhythm problem) is the starting point, and if you want a fuller picture of which conditions and circumstances Mounjaro is indicated for, that context can help you interpret your own experience more accurately. The sensation is real. The catastrophic explanation is usually not.

What actually causes the flutter: physiology, not panic

A few distinct mechanisms can produce palpitations in someone starting or escalating Mounjaro, and knowing which one you are dealing with shapes what to do next.

The first is simple dehydration. Tirzepatide slows gastric emptying, and the resulting nausea can make it genuinely hard to keep fluids down in the early days. Your blood volume drops slightly; your heart compensates by beating faster. This is not specific to Mounjaro (it happens with any illness that reduces fluid intake) but it is particularly common in the dose-escalation phase. Sipping water steadily through the day, even in small amounts when nausea is present, helps substantially. One practical check you can do in under a minute: press your thumbnail briefly against a fingertip, then release it, the pink colour should return within two seconds. Slow return is a reasonable home indicator that you need more fluid.

The second mechanism is the modest heart-rate increase GLP-1 receptor activation can cause. This is well recognised across the GLP-1 class and is why the broader GLP-1 and tirzepatide class overview notes heart rate as something prescribers monitor. It generally settles as the body adjusts to each dose level.

A third, less obvious cause: rapid shifts in blood sugar. People with prediabetes or insulin resistance (a common profile among those starting weight-management treatment) can experience palpitations when glucose levels move quickly, even without hypoglycaemia. This typically resolves as metabolic health improves over weeks of treatment.

Symptoms that change the picture entirely

None of the above should lead anyone to dismiss palpitations entirely. There is a clear line between the unremarkable and the urgent, and it is worth knowing where it sits.

Contact a prescriber promptly, or call 111, if palpitations are accompanied by chest tightness or pain, breathlessness at rest, dizziness that affects your balance, fainting or near-fainting, or if they are frequent and occur even when you are sitting still. These patterns can point to an arrhythmia or another cardiac issue that needs proper assessment, not because Mounjaro caused it, but because it needs ruling out regardless.

The MHRA's Yellow Card scheme allows patients to report suspected side effects from any licensed medicine, including tirzepatide, and doing so contributes to the post-market safety monitoring that keeps prescribing guidance current. If you are unsure whether your palpitations are worth reporting, the answer is usually yes.

People with a known pre-existing arrhythmia or significant structural heart disease should discuss this directly with both their cardiologist and prescribing team before starting or continuing tirzepatide. The full contraindications and precautions are listed in the tirzepatide Summary of Product Characteristics, available on the eMC. For a broader look at how Mounjaro interacts with other health conditions you are managing, the guide to Mounjaro and pre-existing complications covers this territory in detail.

How to have a productive conversation with your prescriber about this

Palpitations are the kind of symptom that is easy to under-report because it feels vague or embarrassing. A few concrete details make the conversation much more useful.

Note when the palpitations happen, at rest, during activity, shortly after injecting, or after eating. Note how long they last and whether anything makes them stop. Note whether you had been vomiting or eating very little that day. That short history gives a prescriber enough to differentiate a dehydration episode from something worth investigating further.

It is also worth flagging any other medicines you are taking. Some medicines (stimulants, decongestants, certain antidepressants) raise heart rate independently, and their combined effect alongside tirzepatide's modest chronotropic action can be additive. The page on Mounjaro and other medications sets out the interaction landscape more fully, and if cannabis is part of your routine, our guidance on using Mounjaro alongside cannabis is also worth reviewing given that it can independently affect heart rate.

At nume, a real clinician reads every consultation. If palpitations are on your mind before you start or during treatment, you can raise them through our prescriber team via our contact page, explore whether treatment is right for you by speaking to our prescribers through the treatment consultation page, or browse our answers to common Mounjaro questions for further reassurance.